NCT02892123 2024-11-27Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing CancersJazz PharmaceuticalsPhase 1 Completed279 enrolled
NCT00001944 2008-03-04Vinorelbine and XR9576 to Treat CancerNational Institutes of Health Clinical Center (CC)Phase 1 Completed30 enrolled